The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A. Voors, Piotr Ponikowski, Christiane E. Angermann et al.|Nature Medicine|2022Cited by 889
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D. Solomon, Subodh Verma, Marco A. Alcocer‐Gamba et al.|New England Journal of Medicine|2024Cited by 693
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled TrialAnders Jorsal, Lise Tarnow, Caroline Kistorp et al.|European Journal of Heart Failure|2016Cited by 561
Prevalence and Prognostic Significance of Hyponatraemia in Outpatients with Chronic Heart FailureLouise Balling, Finn Gustafsson, Morten Schou et al.|European Journal of Heart Failure|2011Cited by 75
Patient Adherence to Evidence-Based Pharmacotherapy in Systolic Heart Failure and the Transition of Follow-Up from Specialized Heart Failure Outpatient Clinics to Primary CareAnne Gjesing, Gunnar Gislason, Morten Schou et al.|European Journal of Heart Failure|2013Cited by 48